middle.news
How Invion’s INV043 Illuminates New Hope for Skin Cancer Patients
1:25am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Invion’s INV043 Illuminates New Hope for Skin Cancer Patients
1:25am on Monday 2nd of June, 2025 AEST
Key Points
No adverse events reported in first six patients
Observable lesion size reduction after single treatment
Patients experienced no pain during treatment
INV043 demonstrated potential as a diagnostic tool
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invion (ASX:IVX)
OPEN ARTICLE